Skip to main content
OpenTrials

Clinical trial condition

Hemic and Lymphatic Diseases

Explore clinical trials studying Hemic and Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

21,127 public trials 3,991 recruiting studies
Refine in advanced search Browse all conditions

Hemic and Lymphatic Diseases trial results

Recruiting

Clinical Trial Assessing the Immunogenicity of an Anti-pneumococcal Vaccination Strategy (PCV13+PPV23 Versus PREVENAR20) in Adult Patients Treated for a Lymphoma

NCT04460235

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Chu Angers Angers, France
  • CHU Bordeaux Bordeaux, France
  • CHU Limoges Limoges, France
  • Chu Nantes Nantes, France
View Trial Details
Recruiting

Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

NCT03128996

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +16 more
Locations
  • Yale School of Medicine New Haven, Connecticut, United States
  • Nemours Children's Health Wilmington, Delaware, United States
  • Helen DeVos Children's Hospital Grand Rapids, Michigan, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Recruiting

Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma

NCT04508790

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope at Seacliff Huntington Beach, California, United States
  • City of Hope at Antelope Valley Lancaster, California, United States
  • City of Hope at Long Beach Elm Long Beach, California, United States
View Trial Details
Recruiting

IASO-782 in Autoimmune Hematological Diseases

NCT06534021

Conditions
Autoimmune Diseases, Autoimmune Thrombocytopenia, Blood Coagulation Disorders, +17 more
Locations
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
  • Institute of Hematology, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
View Trial Details

Related conditions